INV — what changed in the latest 10-Q
A section-by-section comparison of INV's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-13 vs the prior 10-Q · 2026-05-14
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +16 | −9 | ~28 | 16 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 1 |
| Legal proceedings | Text added/removed | 0 | 0 | ~1 | 0 |
| Other information | Text added/removed | +2 | −1 | 0 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Risk factors
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-13
Revenue was $1.0 million and $0.5 million for the three months ended June 30, 2026 and 2025, respectively, an increase of $0.5 million or 100.2%. The increase was driven by an increase of product sales and service revenue in the Technology segment.
Cost of sales was $5.1 million and $2.9 million for the three months ended June 30, 2026 and 2025, respectively, an increase of $2.2 million or 77.3%. The increase related to an increase in revenue in the Technology segment resulting in an increase in costs related to supplies and materials, amortiz…
General and administrative expense was $14.5 million and $18.6 million for the three months ended June 30, 2026 and 2025, respectively, a decrease of $4.1 million, or 21.9%. The decrease was due to a decrease in stock-based compensation costs and a decrease in professional and legal fees.
Goodwill impairment expense was $113.3 million for the three months ended June 30, 2025. The prior-year charge was due to sustained decreases in the Company’s publicly quoted share price and market capitalization, which were sensitive to the general downward volatility experienced in the stock marke…
Sales and marketing expense was $3.1 million and $2.2 million for the three months ended June 30, 2026 and 2025, respectively, an increase of $0.9 million, or 39.9%. The increase was due to increased marketing-related events and expenses primarily associated with the commercialization of the Technol…
Text removed vs the prior filing · source: 10-Q · 2026-05-14
three months ended March 31, 2026three months ended March 31, 2025Change
Change in fair value of financial liabilities63 16,429 (16,366)*
Loss on extinguishment of debt was $1.0 million for the three months ended March 31, 2026. This is due to a loss incurred as a result of the repayment of the Convertible Debentures. There was no loss on extinguishment of debt for three months ended March 31, 2025.
(5) Loss on extinguishment of debt - For the three months ended March 31, 2026 the Company repaid the Convertible Debentures, which resulted in an aggregate of $1.0 million loss on extinguishment of debt. There was no loss on extinguishment of debt for three months ended March 31, 2025. (6) Loss on …
As discussed in more detail below, management has concluded that there is substantial doubt about our ability to continue as a going concern within one year after the date that these condensed consolidated financial statements included in Item 1. of this Form 10-Q were issued. The condensed consolid…
Other information
Text added vs the prior filing · source: 10-Q · 2026-08-13
At this time, Accelsius is party to a purchase order with DarkNX whereby Accelsius is to provide cooling equipment and services concerning six, ten-megawatt deployments. Accelsius has recently been informed that the deployment site identified in the DarkNX purchase order is no longer available. Acce…
During the fiscal quarter ended June 30, 2026, none of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted, modified or terminated a Rule 10b5-1 trading arrangement or a “non-Rule 10b5-1 trading arrangement” (as defined in Item 408 of Regulation S-K).
Text removed vs the prior filing · source: 10-Q · 2026-05-14
During the fiscal quarter ended March 31, 2026, none of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted, modified or terminated a Rule 10b5-1 trading arrangement or a “non-Rule 10b5-1 trading arrangement” (as defined in Item 408 of Regulation S-K).
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice